Articles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Current Editions
Search Archives
BCIQ
Company Profiles
Target Profiles
Product Profiles
Conferences
China Healthcare Summit
Bio€quity Europe
White Papers
Free Trial
/
Subscribe
Sign In
more_vert
Biocentury
Company Profiles
Target Profiles
Product Profiles
Free Trial Information
Export Pdf
Overview
Pipeline
Deals
Financings
Earnings Summary
Stock Summary
Articles
BioCentury
|
Jan 4, 2016
Finance
Curbed enthusiasm
...NYSE) 8/26/15 Up to $1B Mkt (device) Advanced Inhalation Therapies Ltd. 8/25/15 TBD Ph II
Excelsior Biopharma Inc.
...
Read More
BioCentury
|
Oct 5, 2015
Finance
Volatile, not futile
...Inc. 8/17/15 Up to $86.3M Ph II FortuneRock Co. Ltd. (NEEQ) 7/30/15 TBD Ph II
Excelsior Biopharma Inc.
...
Read More
BioCentury
|
Aug 3, 2015
Financial News
Excelsior Biopharma proposes IPO
Excelsior Biopharma Inc.
(TPEx-E:6496), Taipei, Taiwan Business: Cardiovascular, Infectious, Gastrointestinal Date announced: 2015-07-28 Type: IPO To be raised: TBD Shares: TBD Price: TBD Underwriter: KGI Securities Co. Ltd. Note: Excelsior applied for a formal listing...
Read More
BioCentury
|
Dec 22, 2014
Financial News
Excelsior Biopharma financial update
...
Excelsior Biopharma Inc.
(GreTai-E:6496), Taipei, Taiwan Business: Cardiovascular, Infectious, Gastrointestinal Date announced: 2014-12-12 Note:
Excelsior Biopharma
began...
Read More
Items per page:
10
1 - 4 of 4
BioCentury
|
Jan 4, 2016
Finance
Curbed enthusiasm
...NYSE) 8/26/15 Up to $1B Mkt (device) Advanced Inhalation Therapies Ltd. 8/25/15 TBD Ph II
Excelsior Biopharma Inc.
...
Read More
BioCentury
|
Oct 5, 2015
Finance
Volatile, not futile
...Inc. 8/17/15 Up to $86.3M Ph II FortuneRock Co. Ltd. (NEEQ) 7/30/15 TBD Ph II
Excelsior Biopharma Inc.
...
Read More
BioCentury
|
Aug 3, 2015
Financial News
Excelsior Biopharma proposes IPO
Excelsior Biopharma Inc.
(TPEx-E:6496), Taipei, Taiwan Business: Cardiovascular, Infectious, Gastrointestinal Date announced: 2015-07-28 Type: IPO To be raised: TBD Shares: TBD Price: TBD Underwriter: KGI Securities Co. Ltd. Note: Excelsior applied for a formal listing...
Read More
BioCentury
|
Dec 22, 2014
Financial News
Excelsior Biopharma financial update
...
Excelsior Biopharma Inc.
(GreTai-E:6496), Taipei, Taiwan Business: Cardiovascular, Infectious, Gastrointestinal Date announced: 2014-12-12 Note:
Excelsior Biopharma
began...
Read More
Items per page:
10
1 - 4 of 4
Previous page
Next page
